SCHEMBL6946571

SCHEMBL6946571

C#Cc1ccc(Nc2cc(F)ccc2C(=O)O)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 2/20 0.51
MAP2K1 Q02750 3/20 0.44
MAP2K2 P36507 1/20 0.43
IDO1 P14902 1/20 0.40
P2RY4 P51582 1/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
TAS2R14 Q9NYV8 2/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
AKR1C3 P42330 4/20 0.37
AKR1C2 P52895 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951921 0.85 CLCN2 (0.51) CLCN2MAP2K1MAP2K2FABP3FABP4
SCHEMBL6945681 0.83 CLCN2 (0.47) CLCN2MAP2K1IDO1P2RY4MAPK13
SCHEMBL5991985 0.81 MAP2K1 (0.62) MAP2K1MAP2K2
SCHEMBL6951303 0.81 MAPT (0.49) MEN1KMT2AAKR1C3AKR1C2GRIK1
SCHEMBL4855512 0.80 IDO1 (0.61) CLCN2MAP2K1MAP2K2IDO1P2RY4
SCHEMBL6035661 0.80 CLCN2 (0.54) CLCN2MAP2K1MAP2K2IDO1P2RY4
SCHEMBL6946588 0.80 MAP2K1 (0.55) CLCN2MAP2K1MAP2K2TAS2R14ADRA2B
SCHEMBL6948311 0.78 CLCN2 (0.52) CLCN2MAP2K1MAP2K2IDO1P2RY4
SCHEMBL6948484 0.78 MAP2K1 (0.64) MAP2K1MAP2K2MEN1KMT2ATDP1
SCHEMBL6944532 0.78 MEN1 (0.47) CLCN2MAP2K1MAP2K2IDO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
JP-2003504401-A 2003-02-04 JP claimed
CN-1365277-A Methods of treating chronic pain using MEK inhibitors VARNER LAMBERT CO (US) 2002-08-21 CN claimed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP claimed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO claimed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
CN-1365277-A Methods of treating chronic pain using MEK inhibitors VARNER LAMBERT CO (US) 2002-08-21 CN disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed